Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. ESMO Videos
  3. Breast Cancer Videos

Antibody-drug conjugates efficacy and safety in metastatic breast cancer

Breaking Science in Breast Cancer Video Series

Login to get immediate access to this content.

Login

Speaker: Komal Jhaveri, USA

Abstracts discussed:

  • LBA2: Datopotamab deruxtecan (Dato-DXd) vs chemotherapy (CT) in pretreated, inoperable/metastatic HR+/HER2– breast cancer (BC): Additional safety analysis from TROPION-Breast01: View the abstract from ESMO Breast 2024

The speakers and studies featured in this video series were selected independently by ESMO.

Published July 2024

More from this series

Screenshot Guillermo VILLACAMPA
Screenshot Hope RUGO
Screenshot Mafalda OLIVEIRA
Screenshot Matteo LAMBERTINI
Screenshot Peter SCHMID
Screenshot Séverine GUIU

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.